Infraredx Gains Approval in Japan for Its NIR/IVUS Coronary Imaging System

Infraredx has announced that they have received approval in Japan for their TVC Imaging System, the only FDA-approved device to visualize and identify the large lipid core plaques that are thought to be most likely to cause a heart attack. Japan makes up 50% of the worldwide intravascular imaging market. The company, which has partnered with the Japanese firm Nipro, sees this approval as a significant milestone in their expansion strategy.
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news